‘I Could Trust It’: Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell‐Free DNA Screening for Unbalanced Translocations
Prenatal Diagnosis · 2025
DOI: 10.1002/pd.6696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Marta Cifuentes Ochoa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Australia. Hauptthemen laut MEDLINE: Translocation, Genetic, Cell-Free Nucleic Acids, Noninvasive Prenatal Testing, Prenatal Diagnosis. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objective
To explore the experiences of people having cfDNA screening to detect unbalanced translocations, and to understand motivations for choosing this option.
Methods
We used a qualitative approach with in‐depth semi‐structured interviews with reciprocal translocation carriers and their partners. People who underwent cfDNA screening with translocation analysis through Victorian Clinical Genetics Services between 2015 and 2019 were invited to take part. Purposive sampling based on the participant's geographic location, requesting practitioner specialty and cfDNA screening result was used to capture a range of experiences. Interview transcripts were analysed using thematic analysis.
Results
Participants ( n = 13) had complex reproductive journeys associated with the translocation and opted for cfDNA screening rather than prenatal diagnosis to avoid risk to their pregnancy. Participants benefited from having a result early in pregnancy and had sufficient confidence in the result to decline a diagnostic testing procedure.
Conclusion
Participants' experiences with cfDNA screening were intertwined with the experience of being a carrier of a reciprocal translocation. cfDNA screening with translocation analysis was perceived as an acceptable alternative to prenatal diagnosis and should be made more accessible to balanced translocation carriers. Access to specialist genetic counselling services is needed to ensure couples are provided with information about all prenatal testing options, including the benefits and limitations associated with cfDNA screening with translocation analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Parkville, Australia.
- Department of Paediatrics, University of Melbourne, Parkville, Australia.
ORCID-Profile: Marta Cifuentes Ochoa, Alison Dalton Archibald, Nicola Jane Flowers, Mark Domenic Pertile
Zitieren
APA
Cifuentes Ochoa, M., Archibald, A. D., Flowers, N. J., & Pertile, M. D. (2025). ‘I Could Trust It’: Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell‐Free DNA Screening for Unbalanced Translocations. Prenatal Diagnosis. https://doi.org/10.1002/pd.6696
Vancouver
Cifuentes Ochoa M, Archibald AD, Flowers NJ, Pertile MD. ‘I Could Trust It’: Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell‐Free DNA Screening for Unbalanced Translocations. Prenatal Diagnosis. 2025. doi:10.1002/pd.6696
BibTeX
@article{CifuentesOchoa2025,
author = {Cifuentes Ochoa, Marta and Archibald, Alison Dalton and Flowers, Nicola Jane and Pertile, Mark Domenic},
title = {‘I Could Trust It’: Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell‐Free DNA Screening for Unbalanced Translocations},
journal = {Prenatal Diagnosis},
year = {2025},
doi = {10.1002/pd.6696}
}
EUVIMED